Remove 2008 Remove Immunization Remove Vaccines
article thumbnail

Moderna and BioNTech – who are they?

pharmaphorum

Moderna and BioNTech, two rising stars in biotech, were in the limelight this year with their pioneering mRNA vaccines against COVID-19. But the tragic events of 2020 have meant these companies have become household names as their trailblazing mRNA vaccines became the first to be approved by regulators against the COVID-19 scourge.

Vaccines 111
article thumbnail

Prednisone for gout: Dosage, safety, and more

The Checkup by Singlecare

It inhibits the body’s immune system response, decreasing the inflammation and discomfort associated with gout. For example, because it reduces immune resistance, it could make you more susceptible to infection. It might work quickly, too. Some people may feel some relief within an hour.

Dosage 94
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

2022 ISPE Biotechnology Conference: Ongoing Growth & Development

ISPE

The conference focused on the ongoing development and growth in these technologies, and featured speakers on a broad range of topics, including advanced manufacturing and how lessons learned from COVID-19 vaccine development can apply to biologics development. Also having enough glass vials to put the vaccines in!

article thumbnail

Top 20 IPOs in Healthcare by Total Fund Value

PharmaShots

The company’s product portfolio comprises two platforms: Virax Immune, a new-Covid-19 test detecting the T-Cell immune response to the SARS-Cov-2 virus and ViraxClear, a platform to sell a range of highly accurate diagnostic test kits and machines. Founded Year: 2008 No. Funding Value: $7.7M Founded Year: 2021 No.

article thumbnail

Meet the company on a mission to transform research and advance healthcare

Pharmaceutical Technology

You were the chief operating officer (COO) at Viroclinics-DDL before the acquisition, joining Viroclinics-DDL in 2008. The capabilities of Viroclinics and DDL allowed us to rapidly test repurposed drugs, new vaccines and antiviral solutions for the prevention and treatment of patients affected by COVID-19 in 2020.

article thumbnail

The Biotech Effect

Pharmaceutical Technology

We are now one of the ten largest biopharma companies in the world with a rich armoury of new technology, comprising a full suite of technologies, small molecules, antibodies and vaccines to create new human medicines.” The DEEP study results, along with data from further analyses, are under review by a potential licensing partner.

article thumbnail

Contamination Trends & Proposed Solutions

ISPE

Noteworthy cases were the inadvertent introduction of grade 316L stainless steel into Moder-na’s COVID-19 vaccine by the outsourced manufacturer (ROVI Pharma Industrial Services S. In the Moderna COVID-19 vaccine contamination case, three lots of the five lots affected, totaling 1.63 million vials, 26 had to be recalled and destroyed.